Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 16 citing Fonseca: Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients.... (0.10 sec) 

Colesevelam improves glycemic control and lipid management in inadequately controlled …


K Tziomalos, VG Athyros, DP Mikhailidis - Nature Clinical Practice Endocrinology & Metabolism, 2008 - nature.com
VG Athyros is Assistant Professor in Internal Medicine and Academic Head of
Atherosclerosis and Metabolic Syndrome Out-patient Clinics, Second Propedeutic
Department of Internal Medicine, Aristotle University, Hippokration ...
Cited by 3 - Related articles - All 4 versions

American College of Endocrinology Pre-Diabetes Consensus Conference: Part One


ZT Bloomgarden - Diabetes care, 2008 - care.diabetesjournals.org.p.angrylapdog.com
Michael Stern (San Antonio, TX) opened the conference by discussing approaches
to identifying pre-diabetes, noting that, of course, there is always
pre-diabetes before diabetes and that, of course, diabetes is associated ...
Cited by 2 - Related articles - All 11 versions

Quantitative Structure-Property Relationships Modeling to Predict In Vitro and In Vivo …


JR Walker, K Brown, S Rohatagi, MS Bathala … - The Journal of Clinical Pharmacology, 2009 - jclinpharm.highwire.org
Quantitative structure-property relationship (QSPR) models were developed to
correlate physicochemical properties of structurally unrelated drugs with extent
of in vitro binding to colesevelam, and predicted values were compared with ...
Cited by 1 - Related articles - All 3 versions

Colesevelam hydrochloride: a bile acid sequestrant for glycemic control and treatment of …


PN Surampudi, P Nagireddy, VA Fonseca - Therapy, 2009 - Future Medicine
The complications of Type 2 diabetes mellitus (T2DM) include increased risk of
macrovascular diseases such as coronary artery disease, stroke or peripheral
vascular disease, and microvascular diseases such as retinopathy, ...
Cited by 1 - Related articles - All 3 versions

[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last updated …


D Editors
Related articles - All 2 versions

Serum bile acid along with plasma incretins and serum high–molecular weight adiponectin …


H Nakatani, K Kasama, T Oshiro, M Watanabe, … - Metabolism, 2009 - Elsevier
Bariatric surgery has been shown to improve glucose tolerance, although the
mechanism has not been fully elucidated. Animal studies have suggested important
roles of bile acid (BA) as a regulator of energy homeostasis and glucose ...
Related articles - All 9 versions

Clinical practice in type 2 diabetes: After metformin and lifestyle, then what?


ME Cobble, F AAFP - jfponline.com
According to the most recent data from the Centers for Disease Control, nearly
24 million Americans have type 2 diabetes mellitus (T2DM); of these, 6 million
individuals with T2DM remain undiagnosed. At least 57 million more American ...
Cached

Preventing macrovascular complications of diabetes: where do we stand with glycemic …


VG Athyros, K Tziomalos, A Karagiannis, DP … - Expert Opin. Investig. Drugs, 2008 - informahealthcare.com
Diabetes mellitus (DM) is a major vascular risk factor [1,2]. However, it is not
clear whether intensive glucose lowering reduces cardiovascular disease (CVD)
risk in diabetic patients. In the United Kingdom Prospective Diabetes Study ...
Related articles - All 5 versions

Advances in the Treatment of Type 2 Diabetes Mellitus


ZH Israili - American Journal of Therapeutics, 2009 - pdfs.journals.lww.com
There is a rising worldwide prevalence of diabetes, especially type 2 diabetes
mellitus (T2DM), which is one of the most challenging health problems in the
21st century. The associated complications of diabetes, such as ...
Related articles - All 4 versions

[PDF] The Current Unmet Need in Type 2 Diabetes Mellitus: Addressing Glycemia and …


P Levy - Postgraduate Medicine, 2009 - postgradmed.com
Abstract: The treatment of type 2 diabetes mellitus (T2DM) requires a
multifaceted approach of both lifestyle modification (diet, exercise, weight
control, smoking cessation) and pharmacologi- cal therapy. In addition to ...
Related articles


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google